Moodley, S.Gray, A.Schellack, NatalieVenter, F.Suleman, F.Walker, R.B.Choonara, Y.Truter, I.Maimin, J.Malan, S.F.Hattingh, J.Meyer, J.C.Demana, P.Kotze, I.Kubashe, N.Komape, T.K.Van Wyk, S.Eksteen, M.2022-10-182022-10-182021-12Moodley, S., Gray, A., Schellack, N.et al. Pharmacist-initiated management of antiretroviral therapy (PIMART). South African Medical Journal 2021, vol. 111, no. 12, pp. 1162-1163. http://dx.doi.org/10.7196/samj.2021.v111i12.16262.0256-9574 (print)2078-5135 (online)10.7196/samj.2021.v111i12.16262https://repository.up.ac.za/handle/2263/87777We the undersigned, a collective of pharmacy researchers, practitioners and academics, call on the Minister to consider the following points in response to the input made by the South African Medical Association (SAMA) in relation to pharmacist-initiated management of antiretroviral therapy (PIMART), dated 9 September 2021. We wish to highlight the expertise of pharmacists in all matters relating to the design, production and use of quality, safe and affordable medicines. Furthermore, we need to stress the increasing importance of and role played by pharmacists in primary care teams, which has been further reinforced during the COVID-19 pandemic and subsequent vaccination efforts.enThis open-access article is distributed under Creative Commons licence CC-BY-NC 4.0.Pharmacist-initiated management of antiretroviral therapy (PIMART)Antiretroviral therapy (ART)PharmacistsPrimary care teamsArticle